NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-131-2015-2-LT-32 Neutralizing Antibodies to GP120 and Their Use LT EP 16716979.6 Issued
NIAID E-131-2015-2-LU-33 Neutralizing Antibodies to GP120 and Their Use LU EP 16716979.6 Issued
NINDS E-547-2013-0-US-05 Compositions And Methods For Inhibiting JC Virus (JCV) US National Stage 15/023,352 10036020 Issued PDF
NIAID E-131-2015-2-PCT-01 Neutralizing Antibodies to GP120 and Their Use PCT PCT COMB PCT/US2016/023145 Expired
NHLBI E-089-2013-0-US-04 Chemically Defined Culture Medium For Stem Cell Maintenance and Differentiation US National Stage 15/023,221 Abandoned
NIAID E-131-2015-2-EP-10 Neutralizing Antibodies to GP120 and Their Use EP DIV 20156388.9 Pending
NIAID E-131-2015-2-CA-03 Neutralizing Antibodies to GP120 and Their Use CA National Stage 2980005 Pending
NCI E-106-2015-0-PCT-02 Dual Specific Anti-CD22-Anti-CD19 Chimeric Antigen Receptors PCT PCT PCT/US16/023055 Expired
NIAID E-145-2011-0-US-09 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria US DIV 15/072,902 9808458 Issued PDF
NIAID E-128-2015-2-PCT-01 Bank Vole Prion Protein As A Broad-Spectrum Substrate For RT-QUIC-based Detection And Discrimination Of Prion Strains PCT PCT COMB PCT/US2016/022945 Expired
NIAID E-233-2015-0-PCT-02 Intestinal Filarial Antigens For The Development Of Filaria Vaccines PCT PCT PCT/US2016/022787 Expired
NIAID E-233-2015-0-EP-05 Intestinal Filarial Antigens For The Development Of Filaria Vaccines EP National Stage 16765723.8 Abandoned
NIAID E-233-2015-0-AU-03 Intestinal Filarial Antigens For The Development Of Filaria Vaccines AU National Stage 2016233223 Abandoned
NCI E-130-2016-0-US-01 ANTI-pY1235-MET IMMUNOLOGICAL BINDING REAGENT US 62/309,920 Abandoned
NCI E-765-2013-0-US-07 Multifunctional RNA Nanoparticles and Methods of Use US National Stage 15/022,530 10301621 Issued PDF
NIDCR E-619-2013-0-US-03 Methods of Modulating Erythropoiesis with Arginine Vasopressin Receptor 1B Molecules US National Stage 15/022,531 10172911 Abandoned PDF
NIDCR E-123-2016-0-US-01 Adeno-Associated Vectors For Enhanced Transduction and Reduced Immunogenicity US 62/309,025 Abandoned
NCI E-205-2016-0-US-01 Nanoparticle To Target Cancer US 62/309,250 Abandoned
NCI E-074-2007-0-HK-20 BRACHYURY POLYPEPTIDES AND METHODS OF USE HK EP 16103006.8 Issued
NHGRI E-243-2012-1-US-01 Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) US CIP 15/070,787 9944918 Issued PDF
NCI E-267-2015-0-US-01 Inhibitors Of Prokaryotic Gene Transcription and Uses Thereof US 62/308,700 Abandoned
NCI E-229-2018-0-US-01 AZA-A-RING INDENOISOQUINOLINE TOPOISOMERASE I POISONS US 62/308,392 Abandoned
NIAID E-112-2016-0-US-01 Use of CD300B Antagonists to Treat Sepsis and Septic Shock US 62/308,144 Abandoned
NIDA E-053-2016-0-US-01 Dopamine D3 Receptor Selective Antagonists/Partial Agonists; Method of Making; and Use Thereof US 62/307,600 Abandoned
NEI E-050-2015-0-AU-04 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa AU National Stage 2016228751 Issued
NHLBI E-113-2013-0-US-03 Demodulation Of Intensity Modulation In X-ray Imaging US National Stage 15/021,675 9939392 Issued PDF
NEI E-050-2015-0-PCT-03 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa PCT PCT PCT/US2016/022072 Expired
NIAID E-118-2016-0-US-01 Live Attenuated Zika Virus Vaccine US 62/307,170 Abandoned
NEI E-050-2015-0-CA-05 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa CA National Stage 2979229 Pending
NCI E-056-2011-0-SG-46 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer SG DIV 10201601913R Pending
NCI E-191-2016-0-US-01 Methods And Assay Kits For Diagnosing And Prognosing Peripheral T-Cell Lymphoma US 62/306,111 Abandoned
NIAID E-064-2015-2-EP-04 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use EP National Stage 16711090.7 Issued
NIAID E-064-2015-2-DE-06 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use DE EP 16711090.7 Issued
NIAID E-064-2015-2-FR-07 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use FR EP 16711090.7 Issued
NIAID E-064-2015-2-GB-08 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use GB EP 16711090.7 Issued
NCI E-234-2010-1-AU-07 Biomarkers For Prostate Cancer And Methods For Their Detection AU DIV 2016201526 Abandoned
NIAID E-064-2015-2-PCT-01 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use PCT PCT PCT/US2016/021571 Expired
NIAID E-064-2015-2-AU-02 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use AU National Stage 2016229130 Abandoned
NIAID E-102-2016-0-US-01 Recombinant HIV-1 Envelope Proteins and Their Use US 62/306,006 Abandoned
NIAID E-064-2015-2-CA-03 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use CA National Stage 2979038 Pending
NCI E-340-2007-0-US-12 Methods and Compositions for the Treatment of Prostate Related Disorders using miR-1 US DIV 15/062,404 Abandoned
NIDCR E-257-2012-0-US-03 Methods of Preventing the Development of Mucositis and Related Disorders US CON 15/063,256 Abandoned
NCI E-340-2007-0-US-15 Methods and Compositions for Increasing the Efficacy of Doxorubic in Treatment in the Treatment of Prostate Related Disorders using miR-106b-25 Cluster US DIV 15/062,414 Abandoned
NCI E-340-2007-0-US-14 Methods and Compositions for the Treatment of Prostate Related Disorders using miR-32 US DIV 15/062,411 Abandoned
NCI E-340-2007-0-US-13 Methods and Compositions for the Treatment of Prostate Related Disorders using miR-106b US DIV 15/062,407 Abandoned
NIDCD E-043-2016-0-US-01 MICRORNAS AND METHODS OF THEIR USE US 62/304,844 Abandoned
NHGRI E-282-2012-2-US-01 Cannabinoid Receptor Mediating Compounds US CIP 15/061,829 11155521 Issued PDF
NCI E-290-2006-2-US-34 Methods of Inhibiting Tumorigenesis in Colon Adenocarcinoma and Compositions Therefor US DIV 15/057,308 Abandoned
NCI E-166-2007-0-US-07 FILIP1L Nucleic Acid Fragments US DIV 15/058,116 Abandoned
NCI E-281-2016-0-PCT-02 Quinolinones As Inhibitors Of Translation Initiation Complex PCT PCT PCT/US16/020273 Expired